Home › CLEAN › Filing
🔔 Get instant alerts when CLEAN files quarterly results on BSE Start free trial →

Investor Presentation

Filed: 31 Oct 2026, 14:42 IST Exchange: NSE Category: Financial Results — Investor Presentation
Investor Presentation - Q2 FY27 - Consolidated revenue grew 12% y-y to INR 299 Cr; EBITDA margin at 31.2% - CFCL subsidiary added INR ~48 Cr YoY sales and turned PAT positive in Q2 FY27 - Capex of ~INR 150 Cr in H1 FY27 for CFCL; new HALS product commercial launch expected H2 FY27 - HALS segment volume doubled in H1 FY27; top 4 legacy products' share declined to 58% - Balance sheet shows asset monetisation phase with net worth growth and controlled liabilities - Focus on sustainable chemistry, R&D, and global expansion with zero debt and strong governance
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 CLEAN — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add CLEAN to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Clean Science and Technology Limited

Important. The summary above is generated automatically from Clean Science and Technology Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.